RPL19P16

Across TCGA pan-cancer cohorts, RPL19P16 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RPL19P16 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RPL19P16 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL19P16 expression acts as an unfavorable survival marker, although some lineages such as CESC and THCA show a favorable association.

CESC, LIHC, and OV are the cancer types where RPL19P16 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Quartile	All	0.662	0.416	<.001	56	view →
LIHC	DFS	Median	All	0.358	0.503	<.001	55	view →
OV	OS	Quartile	All	0.225	0.369	.001	50	view →
LUAD	OS	Median	III,IV	0.485	0.802	<.001	48	view →
STAD	DFS	Median	II,III,IV	0.441	0.617	<.001	45	view →
THCA	OS	Tertile	All	1.000	0.898	.002	35	view →
SKCM	OS	Median	III,IV	0.776	0.627	.003	19	view →
SARC	DFS	Median	All	0.236	0.434	.007	19	view →
ACC	OS	Quartile	All	0.697	0.935	.022	13	view →
LUSC	OS	Tertile	All	0.440	0.266	.006	9	view →
THYM	DFS	Tertile	II,III,IV	0.606	1.000	.014	8	view →
READ	DFS	Median	All	0.893	0.707	.035	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RPL19P16–CESC (DFS)

Open the CESC breakdown →